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volume and to whether the procedure is carried out in a tertiary specialized hepato-pancreatico-bil-
iary (HPB) unit.
Objective: To evaluate the perioperative outcome associated with pancreaticoduodenectomy in a
newly established HPB unit.
Patients: Analysis of 32 patients who underwent pancreaticoduodenectomy (PD) for benign and
malignant indications.
Design: Retrospective collection of data on preoperative, intraoperative and postoperative care of
all patients undergoing PD.
Results: Thirty-two patients (16 male and 16 female) with a mean age of 59.5 ± 12.7 years were
analyzed. The overall morbidity rate was high at 53%. The most common complication was wound
infection (n= 11; 34.4%). Pancreatic and biliary leaks were seen in 5 (15.6%) and 2 (6.2%) cases,
respectively, while delayed gastric emptying was recorded in 7 (21.9%). The female sex was not
associated with increased morbidity. Presence of co-morbid illness, pylorus-preserving PD,568093862 (A.M. Aziz), tel.:
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48 A.M. Aziz et al.intra-operative blood lossP1 L, and perioperative blood transfusion were not associated with sig-
niﬁcantly increased morbidity. The overall hospital mortality was 3.1% and the cumulative overall
(OS) and disease free survival (DFS) at 1 year were 80% and 82.3%, respectively. The cumulative
overall survival for pancreatic cancer vs ampullary tumor at 1 year were 52% vs 80%, respectively.
Conclusion: PD is associated with a low risk of operative death when performed by specialized
HPB surgeons even in a tertiary referral hospital. However, the postoperative morbidity rate
remains high, mostly due to wound infection. Further improvement by reducing postoperative
infection may help curtail the high postoperative morbidity.
ª 2012 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
The incidence of pancreatic adenocarcinoma is increasing and
because of its silent course, late clinical symptoms and rapid
growth patterns, it has been named the ‘‘silent killer’’ [1,2].
Pancreaticoduodenectomy (PD) is the treatment of choice,
but it is one of the most complex surgical procedures, and is
associated with substantial operative morbidity and mortality
rates. The ﬁrst successful PD was performed by the German
surgeon, Kausch, in 1912 [3], and the operation was popular-
ized in 1935 by Whipple et al. [4], who reported three cases
of pancreaticoduodenal resection. Until the 1980s, the opera-
tive mortality rate of PD was 20–25%, and at one time some
surgeons even proposed that it should be completely aban-
doned as a treatment option for carcinoma of the head of
the pancreas [5,6].
A comprehensive review of the literature that included 1859
patients who underwent pancreatic resection for pancreatic
cancer between 1980 and 1986 showed a mortality rate of
16%, which was unacceptably high when compared with other
types of elective surgery [7]. In the 1990s, several major centers
in western countries reported dramatically reduced operative
mortality rates as a result of improved surgical management
and increased experience [8–16]. An association between high
procedure volume and better patient outcomes has been iden-
tiﬁed for numerous surgical procedures [17–21]. Several studies
have linked the improved operative outcomes after PD in the
1990s with the concentration of case volume in specialized cen-
ters [10–13,15,16]. While an operative or in- hospital mortality
rate of less than 5% had been achieved in high-volume centers,
mortality rates in low-volume hospitals remained in the range
of 13–20% in the 1990s [10–13,15,16]. In centers with a case
volume of more than 40 per year, a mortality rate of less than
2% has been reported [9,14].
The most common indication for PD is carcinoma of the
head of the pancreas [9,13,14]. With the improved safety, PD
is also considered an appropriate treatment for selected patients
with chronic pancreatitis, which is the second most common
indication for the operation in the western series [9,14].
The aim of this article is to evaluate the outcome of PD in
our newly-established specialized unit in Eastern Saudi Arabia,
and compare it with the reports of well-established centers.
Methods
From January 2006 to December 2009, 102 patients with
periampullary tumors were evaluated in King Fahad Specialist
Hospital, Dammam, Saudi Arabia; 32 (31.4%) patients oper-ated on with PD were retrospectively evaluated. All were oper-
ated and managed by a team of surgeons specialized in hepato-
pancreatic-biliary (HPB) surgery. Data on preoperative, intra-
operative and postoperative care were collected and maintained
on a secure database. Preoperative parameters included demo-
graphics, clinical presentation, preoperative risk factors, labo-
ratory testing, and preoperative imaging modalities such as
ultrasound, multi-detector abdominal CT with three-dimen-
sional reconstructions, endoscopic retrograde cholangiopan-
creaticography (ERCP) with or without endoscopic stent
drainage, endoscopic ultrasound and magnetic resonance cho-
langiopancreaticography. Intraoperative details such as opera-
tive time, total blood loss, transfusion needs and the type of
surgical reconstruction were recorded. Postoperative events,
complications, mortality, pathological data were also collected.
Postoperative pancreatic ﬁstula was deﬁned as drainage of
>50 mL per 24 h of ﬂuid, with amylase content >3 times ser-
um amylase activity for >10 d after operation [22]. Periopera-
tive mortality was deﬁned as death in the hospital or within 30 d
[23]. Delayed gastric emptying (DGE) was deﬁned to be present
when nasogastric intubation was maintained for P10 d, com-
bined with at least one of the following: vomiting after removal
of the nasogastric tube, reinsertion of nasogastric tube, or fail-
ure to restore oral feeding [24].
Statistical analysis
All continuous variables were expressed as a mean and stan-
dard deviation (SD) and compared using the Student’s t test.
Categorical variables were compared using the Chi squared
test with Fisher’s exact test to evaluate the impact of clinical
and operative parameters – such as age, sex, any co-morbid ill-
ness, preoperative biliary drainage, nature of disease (malig-
nant vs benign), type of operation (conventional vs pylorus-
preserving PD), operative blood loss, and any perioperative
transfusion – on postoperative morbidity. Survival estimates
were generated using the Kaplan–Meier method. The dis-
ease-free survival (DFS) is deﬁned as the length of time after
surgical treatment during which a patient survives with no
signs of local recurrence or distant metastasis. The overall sur-
vival (OS) is deﬁned as the time elapsed between the date of
admission and the date of last follow up or death. DFS was
calculated from the date of operation to the date of deﬁnite
presence of recurrence or death and the OS was calculated
from the date of diagnosis to the date of death or last follow
up visit. Statistical analysis was performed using SPSS statisti-
cal software. A P value 60.05 was considered statistically
signiﬁcant.
Table 2 Pathologic data for the 32 patients with PD.
Pathological diagnosis Patient No. (%)
Malignant pathology 25 (78.1)
Pancreatic cancer 14 (43.8)
Ampullary carcinoma 9 (28.1)
Duodenal cancer 1 (3.1)
Retroperitoneal germ cell tumor 1 (3.1)
Benign pathology 7 (21.9)
Microcystic cystadenoma of pancreas 2 (6.2)
Intraductal papillary mucinous neoplasm 2 (6.2)
Lymphoplasmacytic sclerosing pancreatitis 1(3.1)
Pancreatic tuberculosis 1 (3.1)
Mucinous cystic neoplasm 1 (3.1)
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There were 16 men and 16 women with a mean age of 59.5
(range, 24–82 years; SD 12.7) years. Twelve patients (37.5%)
were elderly, aged 60 years or older. Twenty-three (71.9%)
patients had one or more chronic co-morbid illnesses, mostly
diabetes mellitus (53%) and hypertension (44%) (Table 1).
Twenty-six patients (81%) underwent ERCP as part of their
preoperative work up, with the insertion of biliary stents in
21 (66%) patients. Ampullary biopsy or brushing was taken
from all patients, but came positive for malignancy in 11
(34%) cases only.
Type of surgery and pancreato-enetric reconstruction
Twenty-one patients (68.8%) underwent the classic PD, 10
(31.2%) pylorus-preserving PD and one (3.1%) underwent total
pancreatectomy. Pancreatico–gastrostomy (PG) was done in 2
patients (6.2%), end-to-side pancreatico–jejonostomy (PJ) in
11 patients (34.4%), end-to-side duct-to-mucosa PJ in 15 pa-
tients (46.9%), end-to-end PJ (dunking) in 2 patients (6.2%),
and pancreatic duct occlusion in 2 patients (6.2%). Two pa-
tients underwent concomitant procedures; segmental transverse
colonic resection (n= 1) and venous patch graft for portal vein
due to tumor inﬁltration (n= 1). The mean blood loss was
902.8 mL (range 300–2000 mL), but 13 (40.6%) patients did
not receive any blood transfusion. Nineteen (59.4%) patients
received a mean blood transfusion of 2.4 (range 1–4) units.
The mean operative time was 6.9 (range from 4 to 12) hours.
Malignant pathology was conﬁrmed in 25 specimens (76%);
the pathological diagnoses of the 32 patients are depicted in
Table 2.Table 1 Demographic and clinical presentation and co-
morbidities for patients with PD.
Variable Patient No. (%)
Age (mean ± SD) 56.3 ± 12.7 years
Male/female ratio 1:1
Symptoms
Jaundice 29 (90.6%)
Abdominal pain 15 (46.9%)
Weight loss 16 (50%)
Nausea 14 (43.8%)
Vomiting 7 (21.9%)
Pruritus 8 (25%)
Bleeding/melaena 2 (6.2%)
Co-morbidity
Diabetes mellitus 17 (53.1%)
Hypertension 15 (46.9%)
Smoking 6 (18.8%)
Ischemic heart disease 3 (9.3%)
Chronic obstructive airway disease 2 (6.2%)
Chronic renal failure 1 (3.1%)
Hyperlipidemia 1 (3.1%)
Neuroﬁbromatosis 1 (3.1%)
Alcoholic 1 (3.1%)
Sheehan’s syndrome 1 (3.1%)
CA 19.9 elevation 21 (66%)Postoperative morbidity
Complications were encountered in 17 (53%) cases. Pancreatic
leak occurred in 5 cases (15.6%) which settled conservatively
except in one case of pancreato–gastrostomy who was operated
upon for gastric bleeding from anastomotic ulcer and oblitera-
tion of pancreatic duct was done using ﬁbrin glue. Biliary leak-
age in 2 cases (6.2%) that did not respond to conservative
treatment was managed by reoperation and repair of the leak.
Bleeding from gastrointestinal anastomosis due to ulceration
occurred in 2 patients (6.2%); one settled conservatively and
the other was complicated by perforation and hence explored
with closure of the site of perforation. Delayed gastric emptying
occurred in 7 patients (21.9%) (4 post-pylorus preservation and
3 after classical PD). Wound infection occurred in 11 patients
(34.4%); 2 (6.2%) were complicated by wound dehiscence,
which was treated by re-suturing. Lymphatic leak occurred in
one patient (3.1%) and was treated by fat-free diet and short
chain fatty acids. The remaining complications are shown in
Table 3. Table 4 shows postoperative morbidity according to
different risk factors. Female gender, presence of co-morbid ill-
ness, pylorus-preserving PD, intra-operative blood loss P1 L,
and perioperative blood transfusion were not associated with
signiﬁcantly increased morbidity. Sixteen patients (50%) had
positive lymph nodes. All patients with positive lymph nodes
or positive surgical margin received either postoperative
chemotherapay or combined chemoradiotherapy.
Postoperative mortality
There was one (3.1%) hospital death in a female patient who
had multiple preoperative co-morbidities (chronic renal fail-
ure, hypertension and diabetes mellitus). The case was compli-
cated postoperatively by pancreatic leak, intra-abdominal
abscess and sepsis that ended by multi-organ failure and death
on the 28th postoperative day.
ICU and hospital length of stay
The mean ICU stay was 5 ± 7 d (range 1–30) and the mean
hospital stay was 23 ± 21.3 d (range 7–96).
Survival
The cumulative overall (OS) and disease free survival (DFS) at
1 year were 80% and 82.3%, respectively (Figs. 1 and 2).The
Table 3 Complications of the 32 patients who underwent PD.
Postoperative morbidity Type of pancreatic drainage Patient No. (%) Treatment
Pancreatic leak 1 PG, 4 PJ duct-to-mucosa 5 (15.6) Conservative
Bile leak 2 PJ duct-to-mucosa 2 (6.2) Reoperation and repair
Pancreatic ﬁstula 1 PG, 1 PJ duct-to-mucosa 2 (6.2) Conservative
GI bleeding 2 PG 2 (6.2) 1 Conservative, 1 reoperation
Delayed gastric emptying 4 PPPD 3 CPD 7 (21.9) Conservative
Others
Gastric leak 1 PG, 1 PJ duct-to-mucosa 2 (6.2) Reoperation
Wound infection 3 PJ end-to-side 11 (34.4) Conservative
6 PJ duct-to-mucosa
2 PG, 1 PD occlusion
Wound dehiscence 1 PJ duct-to-mucosa 2 (6.2) Reoperation
1 PJ end-to-side
Lymphatic leak 1 PJ end-to-side 1 (3.1) Conservative
Pleural eﬀusion 1 PG 4 (12.5) Conservative
2 PJ end-to-side
1 PJ duct-to-mucosa
Chest infection 1 PJ duct-to-mucosa 2 (6.2) Conservative
1 PJ end-to-side
Colonic leak PJ duct-to-mucosa 1 (3.1) Reoperation
Jejunostomy tube leak PJ duct to mucosa 1 (3.1) Conservative
PG : pancreatico-gastrostomy, PJ: pancreatico–jejonostomy, PPPD: pylorus preserving pancreaticoduodenectomy, CPD: classical pancreati-
coduodenectomy, PD: pancreatic duct.
Table 4 Morbidity according to preoperative and operative factors.
Factor Total No. of patients No. of patients with morbidity (%) P value
Age <60 years (n= 20) 9 (45) 0.20
P60 years (n=12) 8 (66.7)
Sex Male (n= 16) 6 (37.5) 0.07
Female (n= 16) 11 (68.8)
Co-morbid illness No (n= 9) 6 (66.7) 0.28
Yes (n= 23) 11 (47.8)
Biliary drainage No (n= 11) 6 (54.5) 0.60
Yes (n= 21) 11 (52.4)
Nature of disease Benign (n= 7) 4 (57.1) 0.57
Malignant (n= 25) 13 (52)
Operation Classical PD (n= 22) 8 (36.4) 0.006a
PPPD (n= 10) 9 (90)
Operative blood loss <1 L (n= 22) 10 (45.5) 0.18
P1 L (n= 10) 7 (70)
Operative transfusion No (n= 13) 6 (46.2) 0.38
Yes (n= 19) 11 (57.9)
PPPD: pylorus-preserving pancreaticoduodenectomy, PD: Pancreaticoduodenectomy.
a P value 6 0.05 was considered statistically signiﬁcant.
50 A.M. Aziz et al.median OS was 45% at 30 months. The cumulative overall sur-
vival for pancreatic cancer vs ampullary tumor at 1 year were
52% vs 80%, respectively (Fig. 3).
Discussion
Many western centers had studied the perioperative morbidity
and mortality of PD during the past decade [8–11,14]. In the
1970s, the mortality rate after PD was approximately 20%,
but in recent decades, morbidity and mortality rates have de-creased due to improvements in perioperative management
and preoperative patient selection [25]. Ho and Heslin in their
study indicated that both increased procedure volume and in-
creased experience are associated with lower mortality rates for
patients undergoing PD [26].
Our results are consistent with the ‘‘practice makes perfect’’
hypothesis originally proposed by Luft et al. [27]. Although in-
creased years of experience are associated with lower mortality
rates, the volume of procedures performed is more critical in
achieving better outcomes. Indeed, all pancreatic resections
Figure 1 The overall survival for the 32 patients with PD.
Figure 2 The DFS survival for the 32 patients with PD.
Figure 3 The overall survival for patients with pancreatic cancer
vs those with ampullary cancer.
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anesthetic care that can be achieved only through high volume
and frequent repetition [10]. Moreover, experience with the
treatment of complications requires the skills of diagnostic
and interventional radiologists, critical care specialists, infec-
tious disease, nursing, and nutritional support services [10];
so complications can be dealt with successfully by a multidis-
ciplinary team. King Fahad Specialist Hospital (KFSH-D) is
a newly established tertiary oncology facility that serves the
population of the Eastern Province of Saudi Arabia (approxi-
mately 2.5 million inhabitants). Prior to establishment of the
HPB section in the Province, majority of patients with pancre-
atic lesions were referred to a tertiary facility in Riyadh.
Unfortunately, data concerning the outcome of PD in Saudi
Arabia is lacking, making comparison of our results with that
of tertiary centers in the country or other gulf countries difﬁ-
cult. Furthermore, comparison of our initial experience, which
is of a small volume, with that reported from larger volume
western units is not justiﬁable. Hence, this retrospective study
was conducted to use the data as a base-line and to evaluateour initial outcome of this operation to establish whether there
is room for further improvement and also to analyze the fac-
tors that may inﬂuence morbidity or mortality after this oper-
ation in our Saudi population.
Despite decrease in reported surgical mortality after PD,
the surgical morbidity remains as high as 46–59% [8,9,14,28–
32]. The operative morbidity rate in our series is 53.1% which
– although high – lies within the range reported from large-
volume centers in the West. This is higher than the reported
morbidity rates of approximately 40% after PD, despite
remarkably reduced mortality rates in recent years
[8,9,14,32]. This can be mainly attributed to the high wound
infection that occurred in 11 cases (34.4%). Reoperation for
postoperative complications was deemed necessary in 6 pa-
tients (18.75%) only. In other studies, reoperation ranged from
3.5% to 17% [14,16,25].
In our series, the pancreatic leakage is 15.6% which is with-
in the rate reported by major western centers (10–20%) after
PD, which has not declined signiﬁcantly in the past 30 years
[32]. Despite intensive effort to prevent pancreatic anastomotic
leakage through the modiﬁcation of surgical techniques or the
use of prophylactic octreotide, none of the measures have been
proven to be effective in reducing the pancreatic leakage rate
[33]. Pancreatic leakage is a potentially serious complication
that can lead to intra-abdominal sepsis and hemorrhage, and
it has been associated with a mortality rate of 20–40% [34].
The high morbidity rate, but lowmortality rate, in this study
indicates that successful management of postoperative compli-
cations, such as pancreatic leak, plays an important role in
achieving low mortality. The concerted efforts of the surgeons,
intensive care staff, interventional radiologists, and clinical
microbiologists in the management of postoperative complica-
tions are critical to the favorable outcome. Further improve-
ment in the operative results of PD relies on measures to
reduce postoperative morbidity. Analysis of risk factors of mor-
bidity revealed that complications were close to signiﬁcant in fe-
male patients (P = 0.07), but not signiﬁcant for the presence of
co-morbid illness, preoperative drainage, nature of tumors,
type of operation, excessive blood loss and blood transfusion.
Moreover, the morbidity rate was similar between elderly and
52 A.M. Aziz et al.younger patients. Better preparation of patients with co-morbid
illnesses and vigilant postoperative care may help reduce mor-
bidity, but complications should be anticipated and managed
in a timely fashion in such patients to avoid mortality. Patients
with adequate preoperative biliary drainage and use of prophy-
lactic antibiotics may help minimize postoperative complica-
tions. The role of preoperative biliary drainage is however
controversial. The data in this study indicate that neither preop-
erative biliary drainage nor ‘no preoperative’ drainage was a
risk factor for postoperative morbidity. Based on retrospective
studies, some authors have reported increased postoperative
morbidity and mortality after PD in patients with preoperative
biliary drainage [35], but others have not observed increased
morbidity associated with preoperative biliary drainage
[36,37]. The role of biliary drainage for jaundiced patients be-
fore PD needs to be evaluated by a prospective randomized
study. Reduction of operative blood loss by meticulous surgical
techniques is probably themost practical measure that surgeons
can employ to reduce postoperative morbidity. Other authors
have demonstrated that operative blood loss is a major risk
factor for complications after PD [38]. Excessive blood loss
increases surgical stress and also entails the need for blood
transfusion, both of which have been shown to exert an immu-
nosuppressive effect and to increase postoperative morbidity,
especially septic complications [39,40].
PD is still a long operation. In our study, the mean opera-
tive time was 6.9 h (range from 4 h to 12 h), which is compara-
ble to other studies [29,34,47]. The mean hospital stay in our
study was 23 ± 21.3 days (range 7–96 d). The hospital stay dif-
fers from study to study according to complications encoun-
tered in each study [25,29].
The hospital mortality rate in this series is 3.1%. In a study
of the results of PD in 39 US hospitals, the hospital mortality
after PD corresponded well to the work volume. Low-, med-
ium-, and high-volume centers for PD were deﬁned as 1–5
cases per year, 6–20 cases per year, and more than 20 cases
per year, respectively. The corresponding hospital mortality
rates were 19%, 12%, and 2.2%, respectively [11]. Other recent
western studies using similar deﬁnitions have reported similar
mortality rates in hospitals with different volumes of pancre-
atic resection [12,41]. Our institution would be classiﬁed as a
medium-volume center according to such deﬁnition, but our
hospital mortality rate was comparable to those mortality
rates of high-volume western centers [11,12,16]. The largest
single-institution experience of PD ever reported in the litera-
ture was from a center with 650 cases of PD between 1990
and 1996 (i.e. >100 cases per year), and the hospital mortality
rate was 1.4 % [14].
The low hospital mortality rate observed in our study is
likely to be related to the management of all patients by a spe-
cialized team of HPB surgeons, even though the case volume
was not high. A study in the UK (1997) has demonstrated sig-
niﬁcantly lower postoperative mortality rate after resection of
pancreatic and periampullary tumors in specialist pancreatic
units compared with general surgical units (average mortality
rate 4.9% vs 9.8%) [13].
A tertiary referral center is likely to offer better facilities
and expertise in perioperative care, such as more sophisticated
diagnostic imaging and radiological interventions, specialized
anesthetic services, and a well equipped intensive care unit.
Poon et al. stated that the experience of the surgical team is
of equal, if not more important, when a complex operationis being performed only once a month or less frequently [42].
It is not only the operative technique, but also the periopera-
tive management, that determine patients’ outcomes [42].
Between 1988 and 1993, 271 Whipple procedures were per-
formed at Johns Hopkins, which enabled them to employ a
dedicated intensive care unit with attending physicians and
specialty support services [15]. This high volume of procedures
led to the formulation of treatment protocols and critical path-
ways for the Whipple procedure, as well as standardization of
diagnostic workups, technical operative details, and manage-
ment of the postoperative course [43]. In a recent study
(1998), hospital rather than individual surgeon’s case volume
was identiﬁed as the most important determinant of hospital
mortality rate after the resection of pancreatic cancer [41]. In
the same study, the authors suggested that the combined ‘expe-
rience effect’ of the whole team of surgeons is more important
than the number of operations performed by a particular
surgeon, and the development of a systematic approach in
perioperative management by a specialized team may be an
important factor for better perioperative outcomes [41].
The association between higher volume and better outcomes
for the Whipple procedure and all types of pancreatic resection
has been used to recommend regionalization of these proce-
dures either through minimum volume standards or referral
of patients to ‘‘centers of excellence’’ [11,12,28,41,43–47].
The low operative mortality rate in our study, together with
the data from western and eastern studies regarding the impact
of hospital volume on perioperative outcomes seem to support
the concentration of complex surgical procedures such as PD
in our tertiary referral centers in the Eastern Province, Saudi
Arabia. However, without a study that compares the operative
outcomes of PD between various tertiary centers and general
surgical units in the region, it is impossible to draw a conclu-
sion. The inﬂuence of any confounding factors such as patient
characteristics that may affect operative results in different
institutions needs to be adjusted in such a study.
Comparing survival following PD for patients with periam-
pullary carcinomas in the last decade with several decades ago,
survival is clearly improved from as high as 25% to as low as
<5% [47]. In a study by Cameron et al. on 1000 PD for pan-
creatic cancer, those who had negative nodes and negative
margins (patients presumably with small early pancreatic can-
cers) the 1-, 3-, and 5-year survival rates were 80%, 49%, and
41%, respectively [47]. The multiple reasons for the improved
survival are not entirely clear. It is unlikely that surgery will
play a signiﬁcant role in the improvement of long-term
survival following PD for periampullary adenocarcinomas.
Further improvement will come from neoadjuvant and/or
adjuvant therapy with radiotherapy and chemotherapy, as well
as with immunotherapy [47]. The past 2 decades have seen a
signiﬁcant improvement in the way periampullary cancers
are managed surgically. The next few decades will witness
the introduction of improved neoadjuvant and adjuvant ther-
apies which will certainly result in signiﬁcant improvements
in long-term survival [47].Conclusion
PD is associated with a low risk of operative death when per-
formed by specialized HPB surgeons even in a tertiary referral
hospital. However, the postoperative morbidity rate remains
Pancreaticoduodenectomy in a tertiary referral center in Saudi Arabia: A retrospective case series 53high mostly due to wound infection. Further improvement by
reducing postoperative infection may help curtail the high
postoperative morbidity.
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